Ikeda Hitoshi, Nagashima Kayo, Yanase Mikio, Tomiya Tomoaki, Arai Masahiro, Inoue Yukiko, Tejima Kazuaki, Nishikawa Takako, Watanabe Naoko, Kitamura Kazuya, Isono Tomomi, Yahagi Naohisa, Noiri Eisei, Inao Mie, Mochida Satoshi, Kume Yukio, Yatomi Yutaka, Nakahara Kazuhiko, Omata Masao, Fujiwara Kenji
Department of Gastroenterology, University of Tokyo, Bunkyo-ku, Japan.
Life Sci. 2006 Apr 4;78(19):2226-33. doi: 10.1016/j.lfs.2005.09.024. Epub 2005 Nov 8.
Use of herbal remedies in the treatment of various diseases has a long tradition in Eastern medicine and the liver diseases are not an exception. In their use, lack of elucidation of mechanism(s) as well as randomized, placebo-controlled clinical trials has been a problem. Recently, we and others reported that inchin-ko-to (TJ-135), one of herbal remedies, suppressed hepatic fibrosis in animal models. In the course of clarifying the mechanism, we directed our focus on hepatic stellate cells (HSCs), playing a pivotal role in hepatic fibrosis, and found that rat HSCs cultured with TJ-135 changed their morphology to star-like configuration with thin, slender and dendritic processes with fewer stress fibers, which might be the features in apoptosis. In fact, TJ-135 induced HSC apoptosis in a time- and concentration-dependent manner as judged by the nuclear morphology, quantitation of cytoplasmic histone-associated DNA oligonucleosome fragments and caspase 3 activity. In HSCs treated with TJ-135, increased expression of p53 and decreased expression of Bcl-2 and phosphorylated Akt and Bad were determined. HSC apoptosis is shown to be involved in the mechanisms of spontaneous resolution of rat hepatic fibrosis and the agent which induces HSC apoptosis has been shown to reduce experimental hepatic fibrosis in rats. Thus, the induction of HSC apoptosis could be the mechanism how TJ-135 works on the resolution of hepatic fibrosis. Our current data may shed light on the novel effect of the herbal remedy.
草药疗法用于治疗各种疾病在东方医学中有着悠久的传统,肝脏疾病也不例外。在其应用过程中,缺乏对作用机制的阐明以及随机、安慰剂对照的临床试验一直是个问题。最近,我们和其他人报道,草药疗法之一的茵陈蒿汤(TJ - 135)在动物模型中可抑制肝纤维化。在阐明机制的过程中,我们将重点放在肝星状细胞(HSC)上,其在肝纤维化中起关键作用,并发现用TJ - 135培养的大鼠HSC将其形态转变为星状结构,具有细小、细长和树突状的突起,且应力纤维较少,这可能是凋亡的特征。事实上,从核形态、细胞质组蛋白相关DNA寡核小体片段的定量以及半胱天冬酶3活性判断,TJ - 135以时间和浓度依赖性方式诱导HSC凋亡。在用TJ - 135处理的HSC中,确定了p53表达增加以及Bcl - 2、磷酸化Akt和Bad表达降低。HSC凋亡被证明参与大鼠肝纤维化自然消退的机制,并且已证明诱导HSC凋亡的药物可减轻大鼠实验性肝纤维化。因此,诱导HSC凋亡可能是TJ - 135作用于肝纤维化消退的机制。我们目前的数据可能会揭示这种草药疗法的新作用。